Trial Profile
Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Basiliximab
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 28 Jul 2016 New trial record